The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
2 Stocks About To Make a Killing on the SpaceX IPO The SpaceX IPO is set to be a major windfall for its investors, but there are other winners that deserve attention.
Are CD Ladders Worth It in April 2026? Want to earn more on your savings the easy way? Learn how a CD ladder works and how it can earn you serious cash this year.
Most Investors Build Their Portfolio Backwards. Here's the Right Order. For many people, their portfolios are just a collection of funds with no structure. Here's the right way to build a portfolio.
Prediction: 1 Artificial Intelligence (AI) Stock Will Quietly Double While the Market Panics Over TurboQuant The launch of Google's TurboQuant has fueled a nasty sell-off in artificial intelligence (AI) memory and storage stocks.
Is Navan Stock a Buy After a Director Purchased Company Shares Worth $1.2 Million? Navan delivers AI-powered travel and expense solutions; a recent insider buy underscores activity in this tech-focused company.
Why Some Investors Are Moving to Cash in 2026: Is That a Mistake? Moving out of stocks and into cash based on short-term events is usually a bad move.
EverCommerce's President Sold 20,000 Company Shares. Here's What It Means for Investors. EverCommerce delivers SaaS solutions for service businesses; a key insider recently reduced their holdings, SEC filings reveal.
A Talos Energy (TALO) Insider Sold 2.3 Million Shares for $38.5 Million. Should You Follow Their Lead? Talos Energy, a Gulf of Mexico-focused oil and gas producer, reported significant insider selling amid a year of sharp share price gains.
Iran Has Threatened America's Tech Giants. Time to Sell? Investors need to look at American tech's Middle East operations as a percentage of the total, not the billions already pledged and invested.
Better Defense Stock: Lockheed Martin vs. RTX With global tensions rising, rising defense spending should provide a strong tailwind for these two companies.
The Metals Company Inc. Just Got Incredible News from the NOAA. Here's What It Means for Investors. In March, The Metals Company proudly announced that its application for deep-sea mining was in "substantial compliance."
3 High-Yield ETFs to Buy With $500 and Hold Forever This trio of high-yield ETFs allows you to be a dividend investor without all the work of picking stocks.
Why Nebius Stock Jumped in March Nebius is quickly growing partnerships with a diverse group of tech hyperscalers.
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock? This biotech focused on pulmonary therapies reported a notable insider sale amid strong share price gains and rising revenue.
This Dividend Stock Is Down 8% and That Makes It One of the Best Buys of the Year Texas Instruments' stock is trading down more than 8% so far this month, driving its dividend yield to nearly 3%.
Is Netflix a Buy After Its Most Recent Price Hike? How much pricing power does the streaming service have left?
Can Ford Justify Record CEO Compensation After Record Recalls? Management knows it has a quality problem and has been tackling it. But progress hasn't been as transparent or obvious as investors would hope.
If You Buy Palantir Stock Today, Here's Where It Could Be in 5 Years Palantir stock has skyrocketed 1,800% throughout the artificial intelligence (AI) revolution.
The S&P 500 Is Down 4% in 2026. Here Is What Long-Term Investors Should Do Now. It's the reaction to market turbulence that separates the average investors from the great ones.
Forced Out of Retirement? Here's Your Financial Game Plan. The right strategy can make this transition a little less destabilizing.
Here's How You Can Still Lower Your 2025 Tax Bill If you haven't filed your 2025 taxes yet, you may be able to save money by contributing to an IRA before April 15. Here's how to do it before the deadline.
E*TRADE Is in Talks With SpaceX to Take the Lead in Its Upcoming IPO E*TRADE is rumored to be in pole position to lead the retail slice of the upcoming SpaceX IPO, potentially leaving traders on other platforms feeling rejected.
Is the Trump Bull Market in Its Final Act? History Offers a Decisive Answer. Historical precedent may be the insurmountable headwind that Wall Street's bull market can't overcome.
Put $25,000 in a High-Yield Savings Account and Here's What Happens The math is straightforward, and keeping your savings in the wrong account is likely costing you thousands.
These 2 Monster Stocks Could Be the Best Investments You Make This Decade As artificial intelligence (AI) infrastructure spending continues to accelerate, two members of the "Magnificent Seven" look particularly appealing as beneficiaries over the next decade.
Should Boeing's Safety and Quality Issues Scare Away Investors? Investors can't ignore Boeing's quality and safety track record. Some market observers say it merits scrutiny, while others believe the worst is behind the company.
McDonald's or Domino's: One of These Is a Screaming Buy Right Now Both are leaders within their area of fast food, but one stands out as the better buy.
After a Monster Run, Is Micron Still Worth Owning? Micron has emerged as a top-performing artificial intelligence (AI) semiconductor stock over the last year.
VOO Is Down 7% From Its January High. The Case for Staying Put Has Never Been Stronger The current pullback in the S&P 500 may be uncomfortable. But it's also common and presents a buying opportunity for savvy investors.
I Was Shocked to See How Much This Fast-Growing Business Is Adding to Walmart's Bottom Line Even at less than 1% of fiscal year 2026 sales, this is already a game changer for the business and the stock.
Wall Street Is Wrong About Oracle -- This $553 Billion Backlog Tells a Different Story for 2026 Wall Street is telling investors that Oracle's future is bleak, but it may not be as troubled as some investors fear.
One Energy Stock I'd Buy Right Now and Never Sell Brookfield Renewable has the potential to produce powerful total returns over the coming decades.
Why Core Scientific Stock Crumbled in March It's accelerating a significant strategic transition.
Spousal Social Security Benefits: 4 Things Retirees Need to Know in 2026 Married couples that don't understand how spousal benefits work could miss out on income in retirement.
Nvidia Stock vs. Broadcom Stock: A Wall Street Analyst Says Buy One and Sell the Other Jay Goldberg at Seaport Research is the only Wall Street analyst with a sell rating on Nvidia.
After Nike's Drop, Here Are the 3 Retail Growth Stocks I'd Buy Today One industry leader's struggles are putting the spotlight on these growth engines.
The Market Is a Mess. Still, These 2 Industrial Stocks Are Worth Buying in April. Rocket Lab and Fluor Corp. maintain their promising outlook despite heavy market volatility.
Walt Disney Has Been a Streaming Story for Years. Here's How The Story Has Changed. After a decade of poor investment returns, investors should be excited for Disney's next chapter.
Should You Buy Netflix Stock Before April 16? The streaming pioneer is essentially flat over the past year, begging the question: Should you buy the stock now?
Copper Miners ETF Is Showing Why You Need to Tread with Caution You shouldn't ignore that the Copper Miners ETF is focused on a highly volatile commodity niche.
Wondering What AGNC Investment Is Worth? The REIT Tells You Every Quarter. AGNC Investment has a massive 14% yield, but don't overlook this important detail if you're considering buying it.
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors. This clinical-stage biotech focused on precision medicines for kidney and metabolic diseases just reported a notable insider sale.
3 High-Yield Stocks to Buy With $1,000 and Hold Forever With yields of up to 5.7%, this trio is known for their ability to pay reliable dividends.
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More This biotech innovator in antibody therapeutics reported a notable insider sale amid a year of dramatic share price gains.
